CDC awarded $279 million to 49 States, DC, and 40 local health departments to help prevent drug overdoses
On Sept. 1, 2023, the U.S. Centers for Disease Control and Prevention (CDC) awarded $279 million to 49…
North Dakota Development Fund invested $3 million in Colossal Biosciences and Mammoth de-extinction
On Sept. 1, 2023, the North Dakota Development Fund, an investment vehicle for the North Dakota Department of…
Biotechnology | Diagnostics | Disease | FDA | Oncology | Radiology | Therapeutics | Women's Health
FDA Cleared 23andMe improved BRCA report for communities underrepresented in genetic testing
On Aug. 31, 2023, the U.S. Food and Drug Administration (FDA) cleared for marketing the updated 23andMe Personal…
Results from single-dose psilocybin randomized clinical trial treatment for major depressive disorder published in JAMA
On Aug. 31, 2023, study results published in JAMA found that psilocybin treatment was associated with a clinically…
COVID-19 | FDA | Infectious Disease | Vaccine
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union
On Aug. 30, 2023, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP)…
Emergentsﾒ NARCANﾮ Nasal Spray launched OTC making it possible for everyone to help save a life from an opioid overdose Emergency
On Aug. 30, 2023, Emergent BioSolutions announced NARCANﾮ Naloxone HCl Nasal Spray 4 mg would be available on…
WHO initiative signed new licensing agreements on COVID-19 technologies
On Aug. 29, 2023, the COVID-19 Technology Access Pool (C-TAP), a multi-stakeholder partnership to facilitate sharing of intellectual…
CTE identified in brain donations from young amateur athletes
On Aug. 28, 2023, in a study of 152 deceased athletes less than 30 years old who were…
MIT and two California universities received $50 million grant for Army research
On Aug. 27, 2003, The Institute for Collaborative Biotechnologies (ICB) announced it was funding a $50 million five…
CDC’s ACIP announced vaccines recommendation for 2023-24 seasonal influenza
On Aug. 25. 2023, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP)…
Eye cell atlas pinpoints where disease-causing genes are expressed, raising hope for inroads against blindness
On Aug. 25, 2023, Harvardﾒs Center for Brain Science announced the ceation of an eye atlas that pinpoints…
U.S. FDA approved first biosimilar to treat Multiple Sclerosis
On Aug. 24, 2023, the U.S. Food and Drug Administration approved Sandoz’s Tyruko (natalizumab-sztn), the first biosimilar to…
City of Hope received $32 million grant to advance novel therapies
On Aug. 24, 2023, researchers at City of Hope announced were awarded $32.3 million from the California Institute…
NIAID-funded study traced evolution of Malaria drug resistance in East Africa
On Aug. 24, 2023, NIAID reported that emerging resistance to common malaria treatments in Uganda could be connected…
CDC reported risk assessment summary for SARS CoV-2 sublineage BA.2.86
On Aug. 23, 2023, the CDC announced it had detected a new SARS-CoV-2 variant labeled BA.2.86. CDC was…
Scientists released the first complete sequence of a human Y chromosome
On Aug. 23. 2023, researchers co-led by University of California, Santa Cruz Assistant Professor of Biomolecular Engineering Karen…
Parkinson’s disease gene variant found in study of some people of African ancestry
On Aug. 23, 2023, a gene variant found almost exclusively in the genomes of people of African ancestry…
Aspirin can help prevent a second heart attack, but most don’t take it
On Aug. 22, 2023, a study led by researchers at Washington University School of Medicine in St. Louis…
Project NextGen awarded over $1.4 billion to develop future of COVID-19 vaccines and therapeutics
On Aug. 22, 2023, the U.S. Department of Health and Human Services (HHS) announced it had awarded more…
Alberta Innovates invested $13.6 million to strengthen Alberta’s technology sector
On Aug. 22, 2023, Alberta Innovates announced that more than $13.6 million will go to 19 partners, across…
U.S. FDA approved ABRYSVO, Pfizer’s vaccine for prevention of RSV in infants through active immunization of pregnant Individuals
On Aug. 21, 2023, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved ABRYSVO (Respiratory…
Maryland Department of Health announced positive case of locally acquired malaria
On Aug. 18, 2023, the Maryland Department of Health has confirmed and reported a positive case of locally…
National Institutes of Health established Maternal Health Research Centers of Excellence
On Aug. 17, 2023, the National Institutes of Health announced it had awarded $24 million in first-year funding…
CPRIT awarded more than $49 million to Texas institutions for cancer research and prevention
On Aug. 16, 2023, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it had approved over…
Pig kidney xenotransplantation performed optimally after 32 days in human body
On Aug. 16, 2023, surgeons at NYU Langone Health announed they had transplanted a genetically engineered pig kidney…
NIH unveiled comprehensive proteogenomic dataset to help cancer researchers unravel molecular mysteries
On Aug. 14, 2023, the National Institute of Health announced that it had released a comprehensive dataset that…
COVID-19 vaccination and boosting during pregnancy benefits pregnant women and newborns
On Aug. 11, 2023, a study funded by the National Institute of Allergy and Infectious Diseases (NIAID) reported…
WHO issued standing recommendations for COVID including Omicron EG.5 variant risk
On Aug. 9, 2023, the World Health Organization (WHO) released standing recommendations for battling COVID-19 and released an…
Biotechnology | Disease | HIV | Influenza | Measles | Medicine | Plague | Polio | Therapeutics | Vaccine
The United Kingdom announced the Vaccine Development and Evaluation Centre
On Aug. 7, 2023, the United Kingdom Health and Security Agency announced the Vaccine Development and Evaluation Centre…
Biotechnology | Medicine | NIH | Therapeutics
Only 1 in 5 U.S. adults with opioid use disorder received medications to treat it in 2021
On Aug. 7, 2023, a National Institute of Health supported study found that in 2021, an estimated 2.5…